Affiliations 

  • 1 Research and Development, Exploristics Limited, Belfast, UK
  • 2 Centre for Interventions in Infection, Inflammation and Immunity (4i), Graduate Entry Medical School, University of Limerick, Limerick, Ireland
  • 3 ICON Plc, Leopardstown, Dublin, Ireland
  • 4 Medical Engineering Design & Innovation Centre, Cork Institute of Technology, Cork, Ireland
  • 5 Acclarogen Ltd, St John's Innovation Centre, Cambridge, UK
  • 6 Academic Unit of Bone Metabolism, Metabolic Bone Centre, Northern General Hospital, Sheffield, UK
  • 7 School of Molecular and Clinical Medicine, Western General Hospital, Edinburgh, UK
  • 8 Bone Research Unit, Cardiff University, Cardiff, UK
  • 9 Osteoporosis Centre, University Hospital Southampton Foundation Trust, Southampton, UK
  • 10 Department of Biomedical Engineering, Faculty of Engineering, University of Malaya, Kuala Lumpur, Malaysia.; Department of Mechanical and Industrial Engineering, Ryerson University, Toronto, ON, Canada
PMID: 27429561 DOI: 10.4137/CMAMD.S38493

Abstract

Raman spectroscopy was applied to nail clippings from 633 postmenopausal British and Irish women, from six clinical sites, of whom 42% had experienced a fragility fracture. The objective was to build a prediction algorithm for fracture using data from four sites (known as the calibration set) and test its performance using data from the other two sites (known as the validation set). Results from the validation set showed that a novel algorithm, combining spectroscopy data with clinical data, provided area under the curve (AUC) of 74% compared to an AUC of 60% from a reduced QFracture score (a clinically accepted risk calculator) and 61% from the dual-energy X-ray absorptiometry T-score, which is in current use for the diagnosis of osteoporosis. Raman spectroscopy should be investigated further as a noninvasive tool for the early detection of enhanced risk of fragility fracture.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.